From the Department of Nuclear Medicine and PET/CT, National Cancer Institute, Bogotá, Colombia.
Clin Nucl Med. 2020 Dec;45(12):1032-1033. doi: 10.1097/RLU.0000000000003388.
A 70-year-old man with prostate adenocarcinoma was diagnosed by transrectal biopsy, with Gleason of 4 + 5 and initial PSA of 225 ng/mL since March 2020. Ga-PSMA PET/CT was performed as part of initial staging. The images showed an enlarged prostate with focal PSMA uptake in both lobes. Retroperitoneal and pelvic lymph nodes with moderate uptake of PSMA were shown. Another finding was a moderate PSMA uptake in the both lung parenchymas associated with opacities in CT. The patient denied any symptoms of coronavirus disease and was referred to the emergency department for RT-PCR COVID-19, and the result was positive.
一位 70 岁男性,因前列腺腺癌经直肠活检确诊,Gleason 评分为 4+5,初始 PSA 为 225ng/mL,自 2020 年 3 月以来。进行 Ga-PSMA PET/CT 检查作为初始分期的一部分。图像显示前列腺增大,两叶均有局灶性 PSMA 摄取。腹膜后和骨盆淋巴结有中等程度的 PSMA 摄取。另一个发现是双肺实质有中等程度的 PSMA 摄取,与 CT 中的混浊有关。患者否认有冠状病毒病的任何症状,并被转至急诊部进行 RT-PCR COVID-19 检测,结果呈阳性。